These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26266098)

  • 61. [Stereotactic body radiation therapy and oligometastases].
    Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
    Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.
    Collen C; Christian N; Schallier D; Meysman M; Duchateau M; Storme G; De Ridder M
    Ann Oncol; 2014 Oct; 25(10):1954-1959. PubMed ID: 25114022
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
    Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
    BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    Wang X; Zamdborg L; Ye H; Grills IS; Yan D
    BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results.
    Pasqualetti F; Panichi M; Sainato A; Matteucci F; Galli L; Cocuzza P; Ferrazza P; Coraggio G; Pasqualetti G; Derosa L; Sollini M; Mannelli L; Ortori S; Monzani F; Ricci S; Greco C; Fabrini MG; Erba PA
    Radiat Oncol; 2016 Jan; 11():9. PubMed ID: 26796633
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease.
    Ning MS; Gomez DR; Heymach JV; Swisher SG
    Transl Lung Cancer Res; 2019 Feb; 8(1):97-106. PubMed ID: 30788239
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
    Doi H; Beppu N; Kitajima K; Kuribayashi K
    Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
    Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
    Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stereotactic radiotherapy in oligometastatic cancer.
    Kennedy TAC; Corkum MT; Louie AV
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S16. PubMed ID: 28917254
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stereotactic body radiation therapy for oligometastases.
    Lo SS; Fakiris AJ; Teh BS; Cardenes HR; Henderson MA; Forquer JA; Papiez L; McGarry RC; Wang JZ; Li K; Mayr NA; Timmerman RD
    Expert Rev Anticancer Ther; 2009 May; 9(5):621-35. PubMed ID: 19445579
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
    Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
    J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
    Bouman-Wammes EW; van Dodewaard-De Jong JM; Dahele M; Cysouw MCF; Hoekstra OS; van Moorselaar RJA; Piet MAH; Verberne HJ; Bins AD; Verheul HMW; Slotman BJ; Oprea-Lager DE; Van den Eertwegh AJM
    Clin Genitourin Cancer; 2017 Oct; 15(5):e773-e782. PubMed ID: 28462855
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma.
    Loi M; Duijm M; Baker S; Rossi L; Grunhagen D; Verhoef C; Nuyttens J
    Radiol Med; 2018 Nov; 123(11):871-878. PubMed ID: 29923086
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stereotactic Body Radiotherapy in the Treatment of Spinal Metastases.
    Katsoulakis E; Kumar K; Laufer I; Yamada Y
    Semin Radiat Oncol; 2017 Jul; 27(3):209-217. PubMed ID: 28577828
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective?
    Jereczek-Fossa BA; Ronchi S; Orecchia R
    Rep Pract Oncol Radiother; 2015; 20(6):472-83. PubMed ID: 26696788
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
    Hong JC; Salama JK
    Cancer Treat Rev; 2017 Jan; 52():22-32. PubMed ID: 27886588
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The radiobiological targets of SBRT: tumor cells or endothelial cells?
    Karam SD; Bhatia S
    Ann Transl Med; 2015 Nov; 3(19):290. PubMed ID: 26697450
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions.
    Couñago F; Luna J; Guerrero LL; Vaquero B; Guillén-Sacoto MC; González-Merino T; Taboada B; Díaz V; Rubio-Viqueira B; Díaz-Gavela AA; Marcos FJ; Del Cerro E
    World J Clin Oncol; 2019 Oct; 10(10):318-339. PubMed ID: 31799148
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The current state of oligometastatic and oligoprogressive non-small cell lung cancer.
    Tumati V; Iyengar P
    J Thorac Dis; 2018 Aug; 10(Suppl 21):S2537-S2544. PubMed ID: 30206497
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radiotherapy for Oligometastatic Lung Cancer.
    Bergsma DP; Salama JK; Singh DP; Chmura SJ; Milano MT
    Front Oncol; 2017; 7():210. PubMed ID: 28975081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.